Article
Human Immunodeficiency Virus Type 1 Drug Resistance Mutations Update.
The Journal of infectious diseases - 1 Dec 2017
Shafer Robert W
Abstract excerpt
As treatment options coalesce around a smaller number of antiretroviral drugs (ARVs), data are emerging on the drug resistance mutations (DRMs) selected by the most widely used ARVs and on the impact of these DRMs on ARV susceptibility and virological response to first- and later-line treatment regimens. Recent studies have described the DRMs that emerge in patients receiving tenofovir prodrugs, the nonnucleoside...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
